Effect of androgen replacement therapy on atherosclerotic risk markers in young‐to‐middle‐aged men with idiopathic hypogonadotropic hypogonadism

By  

CLINICAL ENDOCRINOLOGY, Vol. 82, Iss. 3, 2015-03 ,pp. : 422-428

John Wiley & Sons Inc

Access to resources Recommend Favorite

ABSENCE OF EFFECT OF RECOMBINANT GROWTH HORMONE TO CLASSIC GONADOTROPIN TREATMENT ON SPERMATOGENESIS OF PATIENTS WITH SEVERE HYPOGONADOTROPIC HYPOGONADISM

By Giagulli V. A.  

Archives of Andrology, Vol. 43, Iss. 1, 1999-07 ,pp. : 47-53

Informa Healthcare

Access to resources Recommend Favorite

INDUCTION OF SPERMATOGENESIS BY INGUINAL VARICOCELE REPAIR IN AZOOSPERMIC MEN

By ÇAKAN M.   ALTUĞ U.  

Archives of Andrology, Vol. 50, Iss. 3, 2004-05 ,pp. : 145-150

Informa Healthcare

Access to resources Recommend Favorite

Reversal of isolated hypogonadotropic hypogonadism: long‐term integrity of hypothalamo–pituitary–testicular axis in two men is dependent on intermittent androgen exposure

By  

CLINICAL ENDOCRINOLOGY, Vol. 81, Iss. 3, 2014-09 ,pp. : 473-476

John Wiley & Sons Inc

Access to resources Recommend Favorite

Normosmic idiopathic hypogonadotropic hypogonadism due to a novel homozygous nonsense c.C969A (p.Y323X) mutation in the KISS1R gene in three unrelated families

By  

CLINICAL ENDOCRINOLOGY, Vol. 82, Iss. 3, 2015-03 ,pp. : 429-438

John Wiley & Sons Inc

Access to resources Recommend Favorite